Related Experiment Video
Updated: Aug 6, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 5, 2010
Salbutamol for hyperkalaemia in children
E Helfrich1, T W de Vries, E N van Roon
1Department of Clinical Pharmacy, Medical Spectrum Twente, The Netherlands. apomst@euronet.nl
Acta Paediatrica (Oslo, Norway : 1992)
|January 26, 2002
Summary
Salbutamol effectively and safely lowers high potassium levels in children. This inhaled or infused medication provides a predictable, lasting reduction in serum potassium, making it a preferred treatment for pediatric hyperkalemia.
Area of Science:
- Pediatric Nephrology
- Clinical Pharmacology
- Emergency Medicine
Background:
- Hyperkalemia is a critical condition requiring prompt management.
- Traditional treatments for hyperkalemia have unpredictable efficacy and potential adverse effects.
- Salbutamol has been investigated for managing hyperkalemia in pediatric populations.
Purpose of the Study:
- To evaluate the safety and efficacy of salbutamol in treating pediatric hyperkalemia.
- To establish salbutamol as a preferred treatment option for children with hyperkalemia.
Main Methods:
- Review of clinical trials and case reports on salbutamol administration for hyperkalemia in children.
- Analysis of salbutamol's effects on serum potassium levels.
- Assessment of safety and duration of action.
Main Results:
- Salbutamol, administered via inhalation or infusion, demonstrates significant efficacy.
- Treatment with salbutamol leads to a predictable and sustained decrease in serum potassium.
- The medication is well-tolerated in pediatric patients.
Conclusions:
- Salbutamol is a safe and effective first-line treatment for pediatric hyperkalemia in the absence of arrhythmias.
- Its predictable and long-lasting potassium-lowering effect supports its use.
- Salbutamol facilitates necessary preparations for subsequent treatments like hemodialysis.
Related Concept Videos
01:30Adrenergic Agonists: Therapeutic Uses
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...